Akzo Nobel NV is a holding company, which engages in the manufacture and sale of coating and paint products. engages in the production and marketing of paints and coatings. It operates through the following segments: Decorative Paintings, Performance Paintings, and Corporate and Others. The Decorative Paints segment manufactures and supplies a range of interior and exterior decoration and protection products for professional and do-it-yourself markets. The Performance Coatings segment produces automotive and aerospace; industrial; marine and protective; and powder coatings. The company was founded in 1792 and is headquartered in Amsterdam, Netherlands.

Kyoritsu Seiyaku Corp. engages in the research, development, and production of vaccines and drugs for pets, livestock, and marine animals. It also deals with the manufacture of industrial and general deodorizers. The company was founded on May 19, 1955 and is headquartered in Tokyo, Japan.

Merial SAS develops, manufactures, and distributes pharmaceutical products and vaccines for animals. It provides therapeutic medicines that treat the diseases of dogs, cats, chickens, cows, pigs, and horses. The company was founded in 1997 and is headquartered in Treillieres, France.

Intervet International BV engages in the manufacture and marketing of animal health products. It offers vaccines, anti-infectives, anti-parasitics, feed additives and products for fertility management. The firm products are used for treatment and care of poultry, pigs, cattle, sheep, goats, horses, fish, shrimp and companion animals. The company was founded by Wim Hendrix in 1949 and is headquartered in Boxmeer, the Netherlands.

Veloce BioPharma LLC engages in the development of products for viral, fungal, and bacterial infections. The company is headquartered in Fort Lauderdale, FL.

Weifang Denotek Biotechnology Co., Ltd., established on 2018-06-19, The business scope includes medical device products(Contains in vitro diagnostic reagents,therapeutic biologics,medical diagnostic equipment),Veterinary in vitro diagnostic reagents,Research and Development of Biologics,Production,Sales;Technology and goods import and export business(Except where prohibited by national laws and regulations);Food Safety Testing Instruments,Consumables,Reagent development,Production,Sales;Genetic Testing,Bioengineering technology development,consult,comminicate,transfer,Promotion service.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Part of Zoetis, Inc., Zoetis Services LLC is a company headquartered in Florham Park, NJ, that discovers, develops, manufactures and sells animal health medicines and vaccines.

The Chemo-Sero Therapeutic Research Institute operates as a pharmaceutical company specializing in the field of biotechnology, immunology, hematology, and microbiology. It develops and manufactures vaccines and blood plasma products. The firm's products include human and veterinary vaccines, diagnostic antigens, and treatments for congenital disorders. They also provides newborn screening tests and quality assurance systems solutions. The company was founded on December 26, 1945 and is headquartered in Kumamoto, Japan.

Develops vaccines for livestock viral

Founded in 1968 in Carros close to Nice by Pierre-Richard Dick (DVM), Virbac is dedicated exclusively to animal health. With a turnover of €736 million in 2013, the company ranks today as the 8th largest animal health company worldwide. Its wide range of vaccines and medicines are used in the prevention and treatment of the main pathologies for both companion and food-producing animals. Over the last forty years Virbac has become a recognised expert in the sector, offering products and services that combine quality, effectiveness and convenience for veterinarians, farmers and animal owners. Present in more than 100 countries the company has more than 4,350 employees. Quoted on the Paris Stock Exchange since 1985 Virbac has remained a family company, not only as regards its shareholding but also through its management principles, its culture and its company values. International presence has been an integral part of Virbac's strategy since the very beginning. Starting in 1978, Virbac expansion abroad speeded up progressively in the 1980s and then in the 1990s. Today Virbac is present in all 5 continents, with around 85% of its sales made outside of France.

Weifang Guarantee Biological Technology Co. Ltd. researches, manufactures and wholesales vitro diagnostic products & medical equipment. The company was founded in 1996 and is headquartered in Weifang, China.

Wuhan Keqian Biology is involved in the research and development, production, and sale of veterinary biological products, as well as the provision of technical services for the prevention of animal epidemics. They offer products including a combination vaccine, a vaccine for poultry, a pet vaccine, and a diagnostic reagent.

Virbac Corp. used to provide dermatological and oral hygiene products for pets and companion animals. The company brands included C.E.T. Home Dental Care, Allerderm, Preventic Tick Collars and Per-Tabs. Virbac was formed on March 5, 1999 and it was headquartered in Fort Worth, TX.

Hangzhou Xianzhi Biotechnology Co., Ltd., established on 2009-05-07, Business scope includes biotechnology,biological products,Research and Development of Biological Instruments,consultation service,Technical service and achievement transfer;Wholesale and sales:biological products,biological instrument;Production and processing:bioengineering materials,Biological Reagent Raw Materials; (law,Except for projects prohibited by administrative regulations and involving pre-approval);Import and export of goods and technology(Except for goods and technologies that are restricted or prohibited from import and export by the state).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Suzhou Midi Biotechnology Co., Ltd., established on 2014-08-14, The scope of business includes engaging in technology development in the fields of biomedicine and agriculture,Technical Services,technology transfer;Development and sales of experimental reagents and equipment;Engaged in the import and export business of experimental reagents and equipment.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Qingdao Bolong Genetic Engineering Co., Ltd., established on 2017-02-22, Business scope includes technology development of biopharmaceuticals,technical consulting,Technical Services,Technology Promotion;Medical technology research and development,Technical testing,technical consulting;manufacture:Liquid milk and dairy products(Does not contain dangerous goods),Food and Feed Additives,biology,Biochemicals(Does not contain dangerous goods,In addition to vaccines),Sanitary materials and medical supplies(Does not contain dangerous goods),Veterinary Drugs,cosmetic;wholesale,retail:medicine,food,Green facilities,Disinfectant(Does not contain dangerous goods),medical instruments,Chemical Products(Does not contain dangerous goods),Chemical reagents and products(Does not contain dangerous goods);Agricultural Science Research and Experimental Development;Import and export of goods and technology(Import without publications).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

SyntheX created a novel cell-based, synthetic biology-driven drug selection platform, that allows for the efficient synthesis and identification of peptides and macrocycles that selectively disrupt intracellular protein-protein interactions of interest. Although the platform has broad application, the initial focus is on oncology. Targets are selected based on the concepts of synthetic lethality and oncogene addiction, with the first program focused on DNA damage repair and working through a novel cell death mechanism that was uncovered.